SCOTT C. THOMSON, M.D.
Osteopathic Medicine at La Jolla Village Dr, San Diego, CA

License number
California G053658
Category
Osteopathic Medicine
Type
Emergency Medicine
License number
California G053658
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California G053658
Category
Osteopathic Medicine
Type
Nephrology
Address
Address 2
3350 La Jolla Village Dr, San Diego, CA 92161
17305 Iron Mountain Dr, Poway, CA 92064
Phone
(858) 552-7528
(858) 642-1438 (Fax)
(858) 552-8585

Personal information

See more information about SCOTT C. THOMSON at radaris.com
Name
Address
Phone
Scott Thomson
4125 Faculty Ave, Long Beach, CA 90808
Scott Thomson
4195 26Th St, San Francisco, CA 94131
Scott Thomson
5050 Newport Ave, San Diego, CA 92107
Scott Thomson
3524 E Avenue R SPC 217, Palmdale, CA 93550
Scott Thomson
3524 E Avenue R SPC 47, Palmdale, CA 93550

Professional information

See more information about SCOTT C. THOMSON at trustoria.com
Scott Thomson Photo 1
Shop Tech./Engraver At Fleisher Products

Shop Tech./Engraver At Fleisher Products

Position:
shop tech./engraver at fleisher products
Location:
Greater San Diego Area
Industry:
Graphic Design
Work:
fleisher products - shop tech./engraver


Scott Thomson Photo 2
Professor Of Medicine At Department Of Medicine University Of California San Diego

Professor Of Medicine At Department Of Medicine University Of California San Diego

Position:
Professor of Medicine at Department of Medicine University of California San Diego
Location:
Greater San Diego Area
Industry:
Medical Practice
Work:
Department of Medicine University of California San Diego since 1991 - Professor of Medicine
Education:
UCSD School of Medicine 1979 - 1983
M.D., Medicine
UC Santa Barbara 1974 - 1979
B.S., Physics, Electrical Engineering


Scott C Thomson Photo 3
Dr. Scott C Thomson - MD (Doctor of Medicine)

Dr. Scott C Thomson - MD (Doctor of Medicine)

Hospitals:
3350 La Jolla Village Dr, San Diego 92161
3350 La Jolla Village Dr, San Diego 92161
Education:
Medical Schools
University Of California, San Diego, School Of Medicine
Graduated: 1983


Scott Thomson Photo 4
Method Of Treatment Of Disease Using An Adenosine A1 Receptor Antagonist

Method Of Treatment Of Disease Using An Adenosine A1 Receptor Antagonist

US Patent:
2004022, Nov 18, 2004
Filed:
Feb 23, 2004
Appl. No.:
10/785446
Inventors:
Lauren Otsuki - San Diego CA, US
Howard Dittrich - San Diego CA, US
Kenneth Widder - Rancho Santa Fe CA, US
Roland Blantz - Del Mar CA, US
Scott Thomson - Poway CA, US
International Classification:
A61K031/4745, A61K031/4184, A61K031/401, A61K031/137
US Classification:
514/303000, 514/381000, 514/651000, 514/423000
Abstract:
Disclosed are pharmaceutical composition comprising a beta-blocker and an adenosine Areceptor antagonist (AARA), an angiotensin converting enzyme (ACE) inhibitor and an adenosine Areceptor antagonist (AARA), and an angiotensin II receptor blocker (ARB) and an adenosine Areceptor antagonist (AARA). Also disclosed are methods of treating cardiovascular disease, renal disease, alkalosis, or diabetic nephropathy comprising identifying a patient in need of such treatment, and administering a pharmaceutical composition disclosed herein to said patient.


Scott Thomson Photo 5
Method Of Improved Diuresis In Individuals With Impaired Renal Function

Method Of Improved Diuresis In Individuals With Impaired Renal Function

US Patent:
2006003, Feb 9, 2006
Filed:
Oct 11, 2005
Appl. No.:
11/248479
Inventors:
Kenneth Widder - Rancho Santa Fe CA, US
Lauren Otsuki - San Diego CA, US
Howard Dittrich - San Diego CA, US
Scott Thomson - Poway CA, US
Roland Blantz - Del Mar CA, US
International Classification:
A61K 31/549, A61K 31/522
US Classification:
514263320, 514223500
Abstract:
Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.


Scott Thomson Photo 6
Method Of Improved Diuresis In Individuals With Impaired Renal Function

Method Of Improved Diuresis In Individuals With Impaired Renal Function

US Patent:
2006003, Feb 16, 2006
Filed:
Oct 11, 2005
Appl. No.:
11/248905
Inventors:
Kenneth Widder - Rancho Santa Fe CA, US
Lauren Otsuki - San Diego CA, US
Howard Dittrich - San Diego CA, US
Scott Thomson - Poway CA, US
Roland Blantz - Del Mar CA, US
International Classification:
A61K 31/549, A61K 31/522
US Classification:
514263320, 514223500
Abstract:
Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.


Scott Thomson Photo 7
Method Of Improved Diuresis In Individuals With Impaired Renal Function

Method Of Improved Diuresis In Individuals With Impaired Renal Function

US Patent:
7579331, Aug 25, 2009
Filed:
Apr 23, 2004
Appl. No.:
10/830617
Inventors:
Kenneth J. Widder - Rancho Santa Fe CA, US
Lauren Otsuki - San Diego CA, US
Howard C. Dittrich - San Diego CA, US
Scott Thomson - Poway CA, US
Roland Blantz - Del Mar CA, US
Assignee:
Novacardia, Inc. - San Diego CA
International Classification:
A61K 31/70
US Classification:
514 45
Abstract:
Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.